An article in Nature describes the need for more diversity in genomic research. As of 2018, 78% of data use in genome-wide association studies (GWAS) were derived from people of European descent. Last November, the Consortium sponsored a conference, "Law, Genomic Medicine & Health Equity: How Can Law Support Genomics and Precision Medicine to Advance the Health of Underserved Populations?" Among the speakers was Nanibaa' Garrison (Seattle Children's, University of Washington). Prof. Garrison, a member of the Navajo Nation, works with Native American leaders to address ethical concerns about genetic research within tribal communities. View her presentation, along with a related one by Native scholar Spero Manson (University of Colorado Anschutz Medical Campus). The conference, held at Meharry Medical College, was co-sponsored by the Meharry-Vanderbilt Alliance, and the Minnesota Precision Medicine Collaborative.
MPMC’s new initiative is among the six interdisciplinary projects selected to receive Grand Challenges Research Interdisciplinary Team Awards from the Office of the Executive Vice President and Provost. MPMC II focuses on one of the most mature domains of precision medicine – pharmacogenomics (PGx), which despite its proven scientific basis and immense promise has not yet been widely implemented in healthcare systems.